Evidence map›Paper›PMID 30648910›Full record

ArticleAmerican journal of physiology. Renal physiology2019

Blockade of ERK1/2 by U0126 alleviates uric acid-induced EMT and tubular cell injury in rats with hyperuricemic nephropathy.

Min Tao, Yingfeng Shi, Lunxian Tang, Yi Wang, Lu Fang, Wei Jiang, Tao Lin, Andong Qiu, Shougang Zhuang, Na Liu

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. FOLR1 Regulates the Malignant Progression of Glioblastoma through the SRC/ERK1/2 Axis.Combinatorial chemistry & high throughput screening · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Total extract ofFrontiers in pharmacology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in pharmacology · 2021
    Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Min TaoDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Yingfeng ShiDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Lunxian TangEmergency Department of Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Yi WangDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Lu FangDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Wei JiangDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Tao LinDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Andong QiuSchool of Life Science and Technology, Advanced Institute of Translational Medicine, Tongji University , Shanghai , China.
Shougang ZhuangDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Na LiuDepartment of Nephrology, Shanghai East Hospital, Tongji University School of Medicine , Shanghai , China.
Shanghai East Hospital · CNRhode Island Hospital · USTongji University · CN

Funding

Role of Histone Methyltransferase EZH2 in Acute and Chronic Renal InjuryR01DK113256 · NIDDK · RHODE ISLAND HOSPITAL · PI ZHUANG, SHOUGANG · 2018 to 2021
$1.5M
NIDDK NIH HHS R01 DK113256
6 · The paper itself

Abstract

Extracellular signal-regulated kinases 1 and 2 (ERK1/2) are serine/threonine kinases and function as regulators of cellular proliferation and differentiation. Recently, we demonstrated that inhibition of ERK1/2 alleviates the development and progression of hyperuricemia nephropathy (HN). However, its potential roles in uric acid-induced tubular epithelial-mesenchymal transition (EMT) and tubular epithelial cell injury are unknown. In this study, we showed that hyperuricemic injury induced EMT as characterized by downregulation of E-cadherin and upregulation of vimentin and Snail1 in a rat model of HN. This was coincident with epithelial cells arrested at the G

Indexed as

AnimalsApoptosisButadienesCadherinsCell CycleEpithelial-Mesenchymal TransitionGene SilencingHyperuricemiaKidney DiseasesKidney TubulesLipocalin-2MaleMAP Kinase Signaling SystemMatrix Metalloproteinase 2Matrix Metalloproteinase 9NitrilesButadienesCadherinsLcn2 protein, ratLipocalin-2Matrix Metalloproteinase 2Matrix Metalloproteinase 9Mmp2 protein, ratMmp9 protein, ratNitrilessnai1 protein, ratSnail Family Transcription FactorsU 0126Vimentincell apoptosisepithelial-mesenchymal transitionERK1/2hyperuricemic nephropathyoxidative stress

Identifiers

PMID30648910
PMCPMC6483027
OpenAlexW2909587521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.